Complement-dependent histaminase release from human granulocytes.
Open Access
- 1 June 1979
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 63 (6) , 1195-1202
- https://doi.org/10.1172/jci109414
Abstract
The role of particle-bound complement proteins in the induction of noncytotoxic enzyme release from human granulocytes was investigated with the use of sera genetically deficient in complement and highly purified complement components. Release of histaminase, one of two important histamine catabolizing enzymes, and beta-glucuronidase from polymorphonuclear leukocytes was solely dependent on particle-bound C3b (the larger cleavage product of the third component of complement) when fluid-phase complement was excluded. The extent of enzyme release was a function of particle-bound C3b input, was reduced by exposing the particles to C3b inactivator, and was blocked by fluid-phase C3b. Phagocytosis of the C3b-coated particles was not required for enzyme release from neutrophils. In contrast, phagocytosis of "opsonized" particles was required for noncytotoxic release of histaminase and arylsulfatase from eosinophils; other proteins, as well as C3b, were able to opsonize particles for induction of enzyme release from eosinophils. These studies suggest a dual role for complement (particularly C3) in modulating vascular permeability phenomena, i.e., release of vasoactive mediators by the action of C3a and C5a, and release of the corresponding enzymes that inactivate the mediators by C3b.This publication has 29 references indexed in Scilit:
- Histaminase Release from Human EosinophilsThe Journal of Immunology, 1977
- ComplementAnnual Review of Biochemistry, 1975
- Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.Journal of Clinical Investigation, 1975
- Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.1975
- Inactivation of Slow Reacting Substance of Anaphylaxis by Human Eosinophil ArylsulfataseThe Journal of Immunology, 1975
- HOMOZYGOUS DEFICIENCY OF C3 IN A PATIENT WITH REPEATED INFECTIONSThe Lancet, 1972
- THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITROThe Journal of Experimental Medicine, 1965
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965
- STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENAThe Journal of Experimental Medicine, 1964
- Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum.1956